Medytox Solutions, Inc. Names New Chief Compliance Officer, Steven Burdelski
Burdelski, a Former FBI Executive Manager, to Develop and Maintain Policies and Procedures, Monitor Standards of Conduct
WEST PALM BEACH, FL -- (Marketwired) -- 09/03/15 -- Medytox Solutions, Inc. (OTCQB: MMMS) announces the appointment of Steven Burdelski to the position of Chief Compliance Officer. Mr. Burdelski will lead the compliance department in reviewing and evaluating compliance issues and concerns, ensuring that the board of directors, management, and employees meet the high legal expectations of growing public companies like Medytox Solutions.
Mr. Burdelski previously served as an executive manager of the Federal Bureau of Investigation (FBI), where he was responsible for strategic planning and leadership of all FBI investigative programs such as criminal, cyber, counterterrorism, counterintelligence, and critical incident management, as well as overseeing all administrative functions in the Bureau's Tampa office. He was responsible for daily management of 400 employees to ensure their compliance with organizational policy, as well as federal and state laws. He was also named Inspector in Place for the FBI and was responsible for ensuring corporate and legal compliance to improve performance. Prior to his position at the FBI, Mr. Burdelski served on the Maryland Police Department from 1987 to 1995, where he was promoted to the rank of Sergeant.
"Compliance is, without doubt, one of the biggest considerations in our sector," said Seamus Lagan, CEO of Medytox Solutions, Inc. "We are fully committed to the highest standards and being proactive in compliance in all areas of our business, and Steve's leadership will strengthen our ability to do so."
Mr. Burdelski is the recipient of multiple awards in his previous role at the FBI. He received the FBI Director's Award for "Excellence in Support of the Integrity and Compliance Program," in addition to excellence awards for his investigation of a wide variety of criminal violations, including domestic and international counterterrorism, fraud, robbery, and white collar crime.
"My experience with the Federal Bureau of Investigation has prepared me for complex work in a compliance-driven industry," added Mr. Burdelski. "My investigative capabilities will assist our team in developing new policies and procedures. I look forward to collaborating with Medytox's expanding departments to further refine channels for investigation and resolution."
Mr. Burdelski lives in Hobe Sound, Florida and holds an M.S. in leadership from Palm Beach Atlantic University.
About Medytox Solutions, Inc.: Medytox Solutions, Inc. (OTCQB: MMMS) represents a new generation in healthcare -- where integration leads to higher quality, better outcomes, and greater profitability. Today, Medytox applies its innovative approach to a growing family of companies that includes health IT and analytics, electronic health records software, medical billing, health-sector financing, and a large network of clinical laboratories serving healthcare and mental health providers.
Safe Harbor Statement
This press release contains certain forward-looking information about Medytox Solutions, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "guidance", "expect", "will", "may", "anticipate", "plan", "estimate", "project", "intend", "should", "can", "likely", "could", and similar expressions are intended to identify forward looking statements. These statements include statements about our plans, strategies and prospects. Forward-looking statements are not guarantees of performance. These statements are based upon the current beliefs and expectations of our management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot assure you that the expectations will prove to be correct. Important factors that could cause our actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. You should not place undue reliance on these forward-looking statements, which speak only as of the date such statements are made. Except to the extent required by applicable law or regulation, we undertake no obligation to update or publish revised forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
Source: Medytox Solutions, Inc.
Released September 3, 2015